Improve the Psychological Health of Thyroid Cancer Patients with Mindfulness
By John M. de Castro, Ph.D.
“It turns out that some of the most difficult elements of the cancer experience are very well-suited to a mindfulness practice. When a person gets diagnosed, there’s fear and uncertainty about the future. There’s the loss of routine and predictability. There’s the physical aspect, the treatment or surgery, pain, insomnia, which almost everybody gets, and the post-treatment fatigue. A lot of people find the hardest time is from active treatment to survivorship or post-treatment period where all of a sudden, it’s time to get back to one’s life, but what’s the new normal? For many people, it’s a catalyst or transition period. They look at their life and wonder what’s important. What are my values? What does an authentic life look like? What brings me meaning and purpose?” – Linda Carlson
Receiving a diagnosis of cancer has a huge impact on most people. Feelings of depression, anxiety, and fear are very common and are normal responses to this life-changing and potentially life-ending experience. But cancer diagnosis is not necessarily a death sentence. Over half of the people diagnosed with cancer are still alive 10 years later and this number is rapidly increasing. In the case of Thyroid cancer that number is over 95%. But, surviving cancer carries with it a number of problems. Anxiety, depression, fatigue and insomnia and reduced quality of life are common symptoms in the aftermath of surviving cancer.
Mindfulness training has been shown to help with cancer recovery and help to alleviate many of the residual physical and psychological symptoms, including fatigue, stress, sleep disturbance, and anxiety and depression. In today’s Research News article “Mindfulness-based stress reduction in patients with differentiated thyroid cancer receiving radioactive iodine therapy: a randomized controlled trial.” (See summary below or view the full text of the study at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324610/ ), Liu and colleagues recruited patients with Thyroid cancer who were receiving radioactive iodine treatment and randomly assigned them to either a usual care control condition or to receive a Mindfulness-Based Stress Reduction (MBSR) treatment. The MBSR program consists of 8 weekly 2-hour group sessions involving meditation, yoga, body scan, and discussion. The patients are also encouraged to perform daily practice for 15-45 minutes. They were measured before and after treatment and 3 months later for cancer specific quality of life, depression, and anxiety.
They found that in comparison to baseline and the treatment as usual control group, the patients who participated in MBSR treatment had significantly improved overall cancer specific quality of life, including emotional function and fatigue, and they reported significantly lower levels of anxiety and depression. Importantly, these improvements were still present and significant 3 months after the conclusion of treatment.
These are impressive results that suggest that mindfulness training produces significant and lasting benefits for the psychological well-being of Thyroid cancer patients. These patients have a lot to deal with in fighting their disease. The improvements in psychological well-being are important producing relief of one aspect of cancer so that the patient can better focus on the physical side. These results add Thyroid cancer patients to the growing list of cancer patients helped by mindfulness training.
So, improve the psychological health of thyroid cancer patients with mindfulness.
“MBSR can help to relieve particular symptoms and improve quality of life for people with cancer. It might, improve mood, improve concentration, reduce depression and anxiety, reduce symptoms and side effects, such as feeling sick (nausea), boost the immune system. . . There is no evidence that meditation can help to prevent, treat or cure cancer, or any other disease.” – Cancer Research UK
CMCS – Center for Mindfulness and Contemplative Studies
This and other Contemplative Studies posts are also available on Google+ https://plus.google.com/106784388191201299496/posts and on Twitter @MindfulResearch
Study Summary
Liu, T., Zhang, W., Xiao, S., Xu, L., Wen, Q., Bai, L., Ma, Q., … Ji, B. (2019). Mindfulness-based stress reduction in patients with differentiated thyroid cancer receiving radioactive iodine therapy: a randomized controlled trial. Cancer management and research, 11, 467-474. doi:10.2147/CMAR.S183299
Abstract
Objective
The aim of this study was to evaluate the efficacy of mindfulness-based stress reduction (MBSR) on health-related quality of life (QoL), depression, and anxiety in patients with differentiated thyroid cancer (DTC) receiving radioactive iodine therapy (RIT).
Patients and methods
A randomized controlled trial of MBSR with 120 DTC patients was performed. They were randomly assigned into the MBSR intervention group and usual care (UC) group. An 8-week MBSR program was administered to the MBSR group starting 8 weeks before RIT. Health-related QoL, depression, and anxiety were measured immediately before the start of MBSR (T1), immediately after RIT hospitalization was concluded (1 week after concluding the last MBSR session, T2), and 3 months after RIT hospitalization (T3), using the QoL Questionnaire Core 30 Items (QLQ-C30), Self-rating Depression Scale (SDS), and Self-rating Anxiety Scale (SAS).
Results
Fifty-three patients in the UC group and 49 patients in the MBSR group completed the study and were analyzed. Both the UC and MBSR groups reported low QoL and high SDS and SAS scores immediately after RIT hospitalization. Patients randomly assigned to the MBSR group showed significantly greater improvements in emotional function (P=0.012, d=–0.03 for T2 and d=1.17 for T3), fatigue (P=0.037, d=1.00 for T2 and d=–0.69 for T3), global QoL (P=0.015, d=1.61 for T2 and d=1.56 for T3), depression (P=0.027, d=–1.19 for T2 and d=–0.83 for T3), and anxiety (P=0.043, d=–1.00 for T2 and d=–0.86 for T3).
Conclusion
An 8-week MBSR program significantly improved a wide range of scales in health-related QoL and mitigated depression and anxiety among DTC patients receiving RIT.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324610/